Table 1.
Gene | Position | dbSNP rs# | Amino acid change | CDS | Japanese lung cancer patients (LC-SCRUM-Asia) |
Genome database (freq.) |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zygosity |
Total (N = 350) |
||||||||||||||||||
Hetero |
Homo |
ToMMo (JPN) |
GnomAD |
TOPMed | ExAC | ||||||||||||||
N | freq. | N | freq. | N | freq. | AFR | AMR | ASJ | EAS | NFE | Whole | ||||||||
ACE2 | chrX: 15618865 | - | p.E57G | c.170A > G | 1 | 0.0029 | - | - | 1 | 0.0029 | - | - | - | - | - | - | - | - | - |
chrX: 15610348 | rs2285666 | Intron Variant | c.439 + 4G > A | 51 | 0.1457 | 152 | 0.4343 | 203 | 0.5800 | 0.4973 | 0.2204 | 0.3692 | 0.2590 | 0.5281 | 0.1991 | 0.2324 | 0.2503 | 0.1770 | |
chrX: 15609946 | - | p.Y158C | c.473A > G | 1 | 0.0029 | - | - | 1 | 0.0029 | - | - | - | - | - | - | - | - | - | |
chrX: 15603621 | - | p.V293F | c.877 G > T | 1 | 0.0029 | - | - | 1 | 0.0029 | - | - | - | - | - | - | - | - | - | |
chrX: 15596236 | - | p.S425A | c.1273 T > G | - | - | 1 | 0.0029 | 1 | 0.0029 | - | - | - | - | - | - | - | - | - | |
chrX: 15593829 | rs191860450 | p.I468V | c.1402A > G | - | - | 1 | 0.0029 | 1 | 0.0029 | 0.0035 | 0.0000 | 0.0000 | 0.0000 | 0.0112 | 0.0000 | 0.0006 | 0.0010 | 0.0007 | |
chrX: 15589926 | rs774469453 | splice region variant | c.1665-7delT | - | - | - | - | not detected | 0.0159 | 0.0009 | 0.0211 | 0.0000 | 0.0010 | 0.0006 | 0.0014 | 0.0062 | 0.0050 | ||
chrX: 15589842 | - | p.V581A | c.1742 T > C | 1 | 0.0029 | - | - | 1 | 0.0029 | - | - | - | - | - | - | - | - | - | |
chrX: 15582333 | rs769062069 | p.R708Q | c.2123 G > A | - | - | 1 | 0.0029 | 1 | 0.0029 | - | - | - | - | - | - | 0.0000 | - | 0.0000 | |
chrX: 15582298 | rs41303171 | p.N720D | c.2158A > G | - | - | - | - | not detected | - | 0.0032 | 0.0043 | 0.0155 | 0.0000 | 0.0247 | 0.0153 | 0.0140 | 0.0165 | ||
chrX: 15582250 | - | p.Q736K | c.2206C > A | 1 | 0.0029 | - | - | 1 | 0.0029 | - | - | - | - | - | - | - | - | - |
Gene | Position | dbSNP rs# | Amino acid change | CDS | Japanese lung cancer patients (LC-SCRUM-Asia) |
Genome database |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zygosity |
Total (N = 350) |
freq. |
|||||||||||||||||
Hetero |
Homo |
ToMMo (JPN) | GnomAD |
TOPMed | ExAC | ||||||||||||||
N | freq. | N | freq. | N | freq. | AFR | AMR | ASJ | EAS | NFE | Whole | ||||||||
TMPRSS2 | chr21:42879909 | rs75603675 | p.G8V | c.23 G > T | 3 | 0.0086 | - | - | 3 | 0.0086 | 0.0031 | 0.3279 | 0.2845 | 0.3681 | 0.0141 | 0.4169 | 0.3642 | 0.3516 | 0.3575 |
chr21:42866439 | rs61735791 | p.A65T | c.193 G > A | 4 | 0.0114 | - | - | 4 | 0.0114 | 0.0073 | 0.0010 | 0.0007 | 0.0003 | 0.0003 | 0.0029 | 0.0017 | 0.0020 | 0.0016 | |
chr21:42866388 | rs201679623 | p.Y82D | c.244 T > G | 2 | 0.0057 | - | - | 2 | 0.0057 | 0.0010 | 0.0000 | 0.0000 | 0.0000 | 0.0061 | 0.0000 | 0.0002 | 0.0006 | 0.0005 | |
chr21:42866384 | rs1016773134 | p.P83L | c.248C > T | 1 | 0.0029 | - | - | 1 | 0.0029 | - | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | |
chr21:42866331 | rs574582815 | p.V101l | c.301 G > A | 1 | 0.0029 | - | - | 1 | 0.0029 | - | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | |
chr21:42852497 | rs12329760 | p.V197M | c.589 G > A | 165 | 0.4714 | 49 | 0.1400 | 214 | 0.6114 | 0.3837 | 0.2884 | 0.1722 | 0.1007 | 0.4172 | 0.2474 | 0.2801 | 0.2470 | 0.2502 | |
chr21:42842591 | rs61735794 | p.G422G | c.1266 G > A | - | - | - | - | not detected | - | 0.0057 | 0.0189 | 0.0196 | 0.0000 | 0.0305 | 0.0203 | - | 0.0206 |
Genetic variants are listed if they were detected in a whole-exome sequence or if the AF was more than 0.01 in at least one of the databases.
Position numbers indicate distance from 5′ end of the original exon 1.
ToMMo: The Tohoku Medical Megabank Project, GnomAD: The Genome Aggregation Database, TOPMed: Trans-Omics for Precision Medicine, ExAC: The Exome Aggregation Consortium.
JPN: Japanese, AFR: African-American/African, AMR: Latino, ASJ: Ashkenazi Jewish, EAS: East Asian, NFE: Non-Finnish European.
141 patients have no variant in ACE2 and 127 patients have no vatiant in TMPRSS2. Two patients have two variants in ACE2 and five patients have two variants in TMPRSS2.